Fresh embryo transfer may be a better option than use of frozen embryos for women with a low chance of having a healthy baby by vitro fertilization (IVF), suggests a trial from China published by The BMJ today.
Risk Adjusted Net Present Value: What is the current valuation of Otsuka’s Zipalertinib
The revenue for Zipalertinib is expected to reach an annual total of $47 mn by 2037 in the US based off GlobalData’s Expiry Model. The